These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 11782253)
21. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine. Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169 [TBL] [Abstract][Full Text] [Related]
22. Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons. Castro I; Giret TM; Magnani DM; Maxwell HS; Umland O; Perry JK; Pecotte JK; Brasky KM; Barber GN; Desrosiers RC; Watkins DI J Virol; 2016 Jun; 90(11):5280-5291. PubMed ID: 26984729 [TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation. Duesberg PH Proc Natl Acad Sci U S A; 1989 Feb; 86(3):755-64. PubMed ID: 2644642 [TBL] [Abstract][Full Text] [Related]
24. Persistent infection of baboons and rhesus monkeys with different strains of HIV-2. Castro BA; Nepomuceno M; Lerche NW; Eichberg JW; Levy JA Virology; 1991 Sep; 184(1):219-26. PubMed ID: 1678564 [TBL] [Abstract][Full Text] [Related]
25. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417 [TBL] [Abstract][Full Text] [Related]
26. HIV Interaction With Human Host: HIV-2 As a Model of a Less Virulent Infection. Azevedo-Pereira JM; Santos-Costa Q AIDS Rev; 2016; 18(1):44-53. PubMed ID: 26936760 [TBL] [Abstract][Full Text] [Related]
27. Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses. Santana VC; Almeida RR; Ribeiro SP; Ferreira LC; Kalil J; Rosa DS; Cunha-Neto E Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):1010-6. PubMed ID: 26602876 [TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen. Leung L; Srivastava IK; Kan E; Legg H; Sun Y; Greer C; Montefiori DC; zur Megede J; Barnett SW AIDS; 2004 Apr; 18(7):991-1001. PubMed ID: 15096801 [TBL] [Abstract][Full Text] [Related]
29. Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection. Leligdowicz A; Rowland-Jones S Expert Rev Vaccines; 2008 Apr; 7(3):319-31. PubMed ID: 18393602 [TBL] [Abstract][Full Text] [Related]
30. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Marlink R; Kanki P; Thior I; Travers K; Eisen G; Siby T; Traore I; Hsieh CC; Dia MC; Gueye EH Science; 1994 Sep; 265(5178):1587-90. PubMed ID: 7915856 [TBL] [Abstract][Full Text] [Related]
31. Protective immunity against HIV infection: lessons from HIV-2 infection. Rowland-Jones S Future Microbiol; 2006 Dec; 1(4):427-33. PubMed ID: 17661633 [TBL] [Abstract][Full Text] [Related]
32. Development of an AIDS vaccine: a daunting epidemiological challenge. Nathanson N; Mathieson BJ Eur J Epidemiol; 2005; 20(2):123-6. PubMed ID: 15792276 [No Abstract] [Full Text] [Related]